Green Square Capital Advisors LLC Alaunos Therapeutics, Inc. Transaction History

Green Square Capital Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 14, 2023	SELL	$0.46 - $0.81 $1.25 Million - $2.2 Million	-2,720,000 Reduced 99.63%	10,000 $6,000
Q4 2022 Feb 15, 2023	BUY	$0.5 - $261.0 $825,000 - $431 Million	1,650,000 Added 152.78%	2,730,000 $1.77 Million
Q3 2022 Oct 31, 2022	BUY	$1.04 - $322.5 $239,720 - $74.3 Million	230,500 Added 27.13%	1,080,000 $1.86 Million
Q2 2022 Jul 20, 2022	BUY	$0.41 - $1.24 $348,295 - $1.05 Million	849,500 New	849,500 $1.05 Million

92.6K

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $424M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

Get notified when there are updates to the investment portfolio of Green Square Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Green Square Capital Advisors LLC with notifications on news.